✦ LIBER ✦

SUBCUTANEOUS INFUSION AND INTRAMUSCULAR INJECTION OF DESFERRIOXAMINE IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD

✍ Scribed by HUSSAIN, M

Book ID: 122483965
Publisher: The Lancet
Year: 1976
Tongue: English
Weight: 406 KB
Volume: 308
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(76)92035-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IMPROVEMENT IN IRON STATUS AND LIVER FUN

IMPROVEMENT IN IRON STATUS AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINE

✍ Hoffbrand, A.V.; Gorman, A.; Laulicht, M.; Garidi, M.; Economidou, J.; Georgipou 📂 Article 📅 1979 🏛 The Lancet 🌐 English ⚖ 346 KB

Combined therapy with desferrioxamine an

Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload

✍ S. Daar; A. V. Pathare 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 102 KB

Intravenous and subcutaneous desferrioxa

Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload

✍ G. E. Janka; P. Möhring; M. Helmig; R. J. Haas; K. Betke 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 430 KB

Ten children with transfusion dependent anemias (thalassemia, sideroblastic anemia, congenital pure red cell aplasia) received either intravenous desferrioxamine (DF) in increasing doses up to 450 mg/kg at the time of transfusion or daily subcutaneous DF up to ll0mg/kg on an outpatient basis. No pat

Continuous low-dose subcutaneous desferr

Continuous low-dose subcutaneous desferrioxamine (DFO) to prevent allergic manifestations in patients with iron overload

✍ P. Cianciulli; F. Sorrentino; L. Maffei; S. Amadori 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 128 KB

Listeriosis in patients with long-term h

Listeriosis in patients with long-term hemodialysis and transfusional iron overload

✍ Robert T. Mossey; James Sondheimer 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Studies of variations of subcutaneously

Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children

✍ E. A. Llados i Vallory; R. Girot; G. Lenoir; M. Payet; P. Houze; R. Bourdon 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 377 KB

Desferrioxamine (DFO) plus ferrioxamine (FO) variations and alterations in plasma and urinary iron (Fe) levels were investigated in eight children with thalassaemia major during a 12-h s.c. DFO infusion at a dose of 40mg/kg body weight. During the infusion, blood samples were regularly taken and tot